TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) has shared an update.
Hansoh Pharmaceutical Group Company Limited has announced its upcoming annual general meeting scheduled for June 20, 2025, in Hong Kong. Key agenda items include the adoption of the 2024 financial statements, approval of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, the company seeks shareholder approval for mandates to repurchase shares and issue new shares, reflecting strategic moves to enhance shareholder value and operational flexibility.
The most recent analyst rating on (HK:3692) stock is a Buy with a HK$22.06 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development, production, and sale of innovative drugs and generic pharmaceuticals. The company is listed on the Hong Kong Stock Exchange and is known for its contributions to the healthcare industry.
Average Trading Volume: 12,089,628
Technical Sentiment Signal: Buy
Current Market Cap: HK$157.9B
Learn more about 3692 stock on TipRanks’ Stock Analysis page.